Loading company…
Miracle develops miRNA detection methods and products for disease diagnosis and screening.
Founded in 2021 and based in Suzhou, China, Miracle develops miRNA-based diagnostic technology and products. Its offerings include extraction kits and reverse transcription and qPCR reagents for applications including Alzheimer's disease diagnosis and cancer screening. The company has research and development centers and manufacturing plants in Suzhou, Shenzhen, and Los Angeles. In December 2023, it closed an undisclosed angel round to advance clinical registration of two product pipelines.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in